Volume 25, Number 6—June 2019
Research Letter
Absence of Neospora caninum DNA in Human Clinical Samples, Spain
Table
Types of samples analyzed and demographic and clinical data for 600 patients tested for Neospora caninum parasites, Spain*
Native country | |
---|---|
Spain | 382 (63.7) |
Other† | 36 (6.0) |
Unknown |
182 (30.3) |
Patient clinical information | |
Immune status | |
Immunocompetent | 458 (76.3) |
Immunodepressed or immunosuppressed | 83 (13.8) |
HIV/AIDS | 19 (22.9) |
Chemotherapy | 29 (34.9) |
Organ transplant | 35 (42.2) |
Unknown | 59 (9.8) |
Pregnancy-related disorders | 454 (75.7) |
Seroconversion–infection suspicion and lymphadenopathy | 418 (92.1) |
Spontaneous abortion | 27 (5.9) |
Ophthalmic | 4 (0.9) |
Other fetal signs‡ | 5 (1.1) |
Neurologic and ocular symptoms and conditions§ | 108 (18.0) |
Neurologic condition with ocular signs | 8 (7.4) |
Ophthalmic only | 3 (2.7) |
General signs, n = 38 | 38 (6.3) |
Pneumonia | 24 (63.2) |
Lymphadenopathy | 2 (5.3) |
Hematologic or oncologic | 12 (31.6) |
*Patients were from 12 regions: Andalusia, Aragon, Asturias, Balearic Islands, Cantabria, Castile-La Mancha, Castile and Leon, Extremadura, Galicia, Madrid, Navarre, Valencia.
†Africa, 8; Asia, 1; Europe, 8; Latin America, 19.
‡Anencephaly, malformations, and microcephaly.
§Neurologic symptoms and conditions include ataxia, disorientation, sudden blindness, encephalitis, calcifications, and intracranial space occupying lesions; ophthalmic symptoms and conditions include chorioretinitis, panuveitis, posterior uveitis, and vitritis.